EN

Enzon Pharmaceuticals IncOOTC ENZN Stock Report

Last reporting period 30 Jun, 2024

Updated 15 Nov, 2024

Last price

Market cap $B

0.009

Micro

Exchange

OOTC - OTC

ENZN Stock Analysis

EN

Uncovered

Enzon Pharmaceuticals Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

99/100

Moderate score

Market cap $B

0.009

Dividend yield

59.04 %

Shares outstanding

74.215 B

Enzon Pharmaceuticals, Inc. is a biopharmaceutical company. The company is headquartered in Cranford, New Jersey and currently employs 0 full-time employees. The firm intends to become an acquisition platform. The firm utilizes its net operating loss carryforwards (NOLs) and improves stockholder value. The company manages its source of royalty revenues from existing licensing arrangements with other companies.

View Section: Eyestock Rating